May 1, 2024
Register to attend this live session hosted by Vicente’s Psychedelics & Emerging Therapies team on Thursday, May 23, 2024. We will dive into the rules and discuss what you need to know to be prepared to participate in Colorado's Natural Medicine program launching on January 1, 2025!
By Vicente LLP, Psychedelic Alpha
Apr 30, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #11 features summaries of the draft rules covering licensing and financial interests and general/operational rules, the stakeholder meeting feedback on those rules, and notes from the combined subcommittee meeting on April 12 and the full Natural Medicine Advisory Board meeting on April 19.
Apr 30, 2024
Are you an entrepreneur or current hemp business interested in entering Kentucky's upcoming medical cannabis market or current hemp market? Watch this recorded session to receive the valuable information you need to get started. Vicente’s cannabis and hemp attorneys will dive into Kentucky’s medical cannabis and adult-use cannabinoid programs, discuss the markets and licensing opportunities, and offer best practices to help you reach your business goals in this new market.
By Barine Majewska
Apr 24, 2024
DORA recently presented additional draft rules for Colorado’s regulated natural medicine market to the Natural Medicine Advisory Board, focused on facilitator conduct and relationships, administrative sessions, informed consent, record keeping and advertising. DORA will host a virtual public hearing on the new rules on April 26 and the Natural Medicine Division of the Department of Revenue will host a stakeholder meeting on Healing Center requirements on May 1. These are important opportunities to make your voices heard! Read this article for details on the rules and instructions for joining the meetings.
Apr 22, 2024
Curious about microdosing psychedelics? Join Vicente LLP psychedelics attorney Joshua Kappel on April 25 at NeueHouse in New York City for a night filled with education, resources, and legality around microdosing. RSVP now!
Apr 12, 2024
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
By Vicente LLP, Psychedelic Alpha
Apr 9, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #10.1 features Vicente LLP's review of SB 24-198, the first legislative update since the passing of SB23-290 in 2023, which implemented the NMHA.
By Daniel Molina, Shawn Hauser
Apr 9, 2024
Every four years, Texas agencies must review adopted rules and that time has come for the Lone Star State's Consumable Hemp Program. As businesses and consumers navigate the Texas hemp market, it's important to understand the rules, rulemaking process, and impending deadlines. If you participate in Texas' booming hemp market, now is the time to make your voices heard as the comment period for this rule review is open through April 22, 2024.
By Vicente LLP, Psychedelic Alpha
Apr 6, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #10 focuses on updates from the recent meeting of the Natural Medicine Advisory Board, where draft rules for Facilitator licensing and training were discussed.
Apr 5, 2024
Vicente LLP founding partner Joshua Kappel and counsel Barine Majewska will be at the upcoming “Cultivating Roots for Cultural Change: the Bay Area’s Annual Spring Conference on Plant Medicines & Psychedelic Science.” Hosted by Chacruna, the event will take place on April 27 and 28, 2024, at the historical Brava Theater Center in San Francisco, California.
Apr 5, 2024
On April 18, 2024, Vicente LLP attorneys Joshua Kappel and Barine Majewska will attend the “Bridging the Worlds: The Confluence of Indigenous Wisdom and Psychedelic Science” conference at the University of Colorado Anschutz Medical Campus in Aurora, CO. Vicente is a sponsor of the event, which will explore the future of psychedelic research in the context of its historical and cultural significance.
Mar 28, 2024
Watch this pre-recorded session to learn about the future of intellectual property for cannabis and hemp products with rescheduling on the horizon. This webinar will feature a discussion with VLLP IP specialists regarding patent, IP and trademark protection, cannabis research, and what may change with potential federal marijuana rescheduling.
By Vicente LLP, Psychedelic Alpha
Mar 20, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #9 focuses on updates from the recent meeting of the Natural Medicine Advisory Board and listening sessions held by the Department of Revenue and the Department of Regulatory Agencies Stakeholder Engagement Meeting.
Mar 15, 2024
On April 2, The Emerald Conference will feature a talk by Vicente LLP director of economics and research Andrew Livingston on how variations between the cannabis and psychedelic markets may influence research design, data collection, and overall program evaluation. Register to attend and learn more!
By Sally Kent Peebles
Mar 7, 2024
The Florida legislature has passed a bill, SB 1698, that will limit the amount of THC allowed in hemp-derived products and ban the sale of products containing certain substances like delta-8 THC. This comes amid a trend of stricter hemp regulations across the US. This Insights post summarizes the key points of the new Florida law and highlights the challenges faced by the hemp industry due to evolving regulations.
By Vicente LLP, Psychedelic Alpha
Mar 5, 2024
Vicente LLP provides a full breakdown of the first set of draft rules regarding Colorado's regulated psychedelics program. The thirty-nine pages of draft rules cover facilitator licensing and training programs, representing months of work by the Natural Medicine Advisory Board and state regulators.
Mar 4, 2024
Join Vicente LLP partner Michelle Bodian on Thursday, April 11, 2024, at the NOCO Hemp Expo in Estes Park, Colorado for her speaking session “Navigating the Hemp Haze: State of the Union on Intoxicating Hemp Products”. Register now!
Mar 4, 2024
Join Vicente LLP partner Michelle Bodian on Friday, March 22, 2024, at 3:00 p.m. ET during the New England Cannabis Convention in Boston at the Hynes Convention Center for her panel “Blink and You’ll Miss It! The Evolution of Hemp Cannabinoids.” You won’t want to miss it!
By Yolanda Clarke
Feb 27, 2024
Oregon's psilocybin program has updated its regulations, clarifying existing rules and addressing new areas like data reporting and facilitator training. Key changes involve distinguishing between mandatory anonymized data collection and optional personal information from clients, requiring state licensing or specific exemptions for facilitator training programs, and emphasizing nondirective facilitation with support resources instead of advice. Read this Insights post to learn more about the recent rule changes for psilocybin in Oregon.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 27, 2024
Vicente LLP shares a high-level overview of the first draft rules for Colorado's regulated natural medicine market. These draft rules focus on facilitator qualifications, education requirements, and training programs.
Feb 20, 2024
Federal and international law and policy insights, news and events from Vicente LLP
Feb 20, 2024
Sign up for Hemp and Cannabinoid Industry updates from Vicente LLP
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 15, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #8.1 gives context to the 123 recommendations which will form the basis of the regulated nature medicine program approved by Colorado voters in November 2022.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 14, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #8 focuses on updates on the NMAB's initial set of recommendations for the state’s regulated natural medicine program
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Jan 18, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #7 focuses on updates from the recent subcommittee meetings.
Jan 11, 2024
The International Cannabis Bar Association (INCBA) will feature Vicente LLP partner Shawn Hauser in an upcoming webinar, "Is the Grass Really Greener? Law & Policy Primer for Cannabis Operators Considering Hemp" on January 17, 2024. Register now!
By Andrea Golan
Dec 19, 2023
In our second blog in a series of Vicente Insights discussing hemp regulation under the new Minnesota Cannabis Law, we break down Minnesota’s regulation of “synthetic cannabinoids” including how they are defined, when they can be used, and whether the rules for synthetic cannabinoids differ for cannabis and hemp.
Dec 19, 2023
On Wednesday, January 10, 2024, Vicente LLP partners Shawn Hauser and Sally Kent Peebles will be participating in a psychedelics investor forum in Nosara, Costa Rica! This is a one-of-a-kind event dedicated to exploring the latest national legislation and its pivotal impact on mental health. Register now!
Dec 19, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Dec 14, 2023
Sign up for Hemp and Cannabinoid Industry updates from Vicente LLP
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Dec 13, 2023
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #6 focuses on updates from the recent subcommittee meetings and the full meeting of the Natural Medicine Advisory Board.
By Jason Adelstone
Dec 7, 2023
On October 27, 2023, the Ninth Circuit Court of Appeals, in Aggarwal v. DEA, held that the U.S. Drug Enforcement Agency (DEA) must reconsider its denial of a petition to transfer psilocybin, the active ingredient in “magic mushrooms” from Schedule I to Schedule II. Read this Insights post for more information about the Ninth Circuit Court’s order to reschedule psilocybin.
Nov 29, 2023
Vicente LLP psychedelics attorneys Joshua Kappel and Shawn Hauser were selected to speak on panels focused on functional alcohol substitutes and psilocybin medicine during the Psychedelics Track at SXSW in March 2024.
By Andrea Golan
Nov 16, 2023
In this first post in a series of Vicente Insights discussing hemp regulation under the new Minnesota cannabis law, we will dive into the licenses and endorsements required to cultivate, process, manufacture, transport, and sell hemp ingredients and hemp products.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Nov 14, 2023
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #5 focuses on updates from the October subcommittee meetings and the full meeting of the Natural Medicine Advisory Board.
Nov 2, 2023
Watch as panelists address the current lab testing and compliance issues in the industry, testing standards across the country, and the importance of reliable testing.
Oct 26, 2023
Vicente LLP founding partner Joshua Kappel will discuss the new age of psychedelics and how natural medicines can help entrepreneurs at the prestigious Inc. 5000 Conference & Gala on November 1.
Oct 26, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Oct 24, 2023
As part of the pre-rulemaking process, the Colorado Department of Revenue's Natural Medicine Division began holding public “Listening Sessions” with the goal of gathering information from the public at large. The October sessions consisted of five, one-hour, online meetings focused on specific topics announced in advance. Read this article for a summary of the first five sessions.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Oct 17, 2023
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #4 focuses on updates from the September subcommittee meetings and the full meeting of the Natural Medicine Advisory Board.
Oct 17, 2023
Watch Vicente LLP partner Shawn Hauser present on Thursday, November 9 during Wonderland Miami! Shawn is slated to discuss the state of the emerging psychedelics industries in Oregon and Colorado. Register now!
Oct 13, 2023
Sign up for Hemp and Cannabinoid Industry updates from Vicente LLP
By David M. Ullian, Gabriel Amatruda
Oct 5, 2023
Public support for medical cannabis in North Carolina is quite strong and despite being one of only a few states that have legalized medical or adult use, cannabis is finally making headway in the Tar Heel State. Read this article to learn about recent cannabis and hemp developments in NC, including legislation and the Eastern Band of Cherokee Indians’ vote to legalize adult-use cannabis.
Oct 2, 2023
Joshua Kappel is a featured speaker at the Psychedelic Missouri Freedom Conference, which will be held on October 21. His panel discussion, “Decriminalizing & Commercializing Psychedelics,” will also feature Andreas Met of Satya Therapeutics and Saint Louis University adjunct professor Charlotte Jones.
Sep 18, 2023
Join the Vicente LLP team in Minneapolis for another can’t-miss hemp and cannabis legal and business seminar on October 19, 2023. The event will feature Vicente LLP hemp and cannabis business attorneys Michelle Bodian, Travis Copenhaver, Jeremy Shaw and Jason Tarasek, along with special guests Sen. Lindsey Port and cannabis accountant Angela L’Esperance of Ms. Jane Accounting.
Sep 11, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Sep 11, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Sep 7, 2023
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #3 focuses on updates from the August subcommittee meetings and the full meeting of the Natural Medicine Advisory Board. In addition, the Department of Revenue will hold NMHA listening sessions throughout September.
Aug 29, 2023
What are the latest updates on Natural Medicines in Colorado? What are the opportunities for entering Colorado’s psychedelic ecosystem? Attend Joshua Kappel and Yolanda Clarke’s sessions at PsyCon Denver on September 29 to find out the answers to these questions. Register now!
Aug 28, 2023
What’s the latest with the 2023 Farm Bill? Andrea Golan will offer an update on the current legal landscape of intoxicating and synthetic cannabinoids in the US at the 2023 Hemp Industries Association Conference. Register now!
By Andrea Golan
Aug 23, 2023
Minnesota's new adult-use cannabis law makes some significant changes to the state's existing rules governing the manufacture and sale of hemp-derived cannabinoid products. Read this article for information on some of the most notable changes, including seller registration requirements, prohibited products, and cannabinoid serving limits.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 14, 2023
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #2 focuses on updates from the July subcommittee meetings and full meeting of the Natural Medicine Advisory Board.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 14, 2023
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #1 focuses on the Natural Medicine Advisory Board: What is the board, how does the board work, what subcommittees exist, what have they done so far, and what's next?
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 11, 2023
Vicente LLP is collaborating with Psychedelic Alpha to produce the Colorado Natural Medicine Health Act Tracker, which is dedicated to being a clearinghouse for the implementation of Colorado’s Natural Medicine Health Act, with a focus on the work of the Natural Medicine Advisory Board and its subcommittees.
By Katelin Edwards, Andrea Golan
Aug 1, 2023
Between an unfavorable court ruling and an uninspiring 2021 legislative session, not to mention a major drought impacting all Texas crops, things were not looking good for hemp in Texas going into the 2023 legislative session. Then, many of the promising bills introduced in the 2023 legislative session were unsuccessful. Where does the Texas hemp market go from here? Read this article for four predictions from Vicente's hemp team.
Jul 12, 2023
Learn about and support psychedelic policy by attending a community educational forum on psilocybin, featuring Vicente LLP founding partner Joshua Kappel, at the West Hollywood City Council Chambers on July 25, 2023. The educational forum will explore the full spectrum of psilocybin-related topics, including a discussion of past and current legislation aimed at decriminalizing psilocybin mushrooms and other hallucinogenic substances.
Jul 7, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Jun 15, 2023
Watch this session replay with Vicente LLP's hemp team and regulators from Colorado and Vermont to learn more about state legislative changes and projections for future hemp product regulation at the state and federal levels.
Jun 7, 2023
The largest psychedelic gathering in history is coming to Denver June 19-23 and Vicente LLP is ecstatic to sponsor the conference and welcome the global psychedelic community to our hometown. Let’s connect at the conference and the many networking events that week!
May 29, 2023
Colorado is the first state to decriminalize natural psychedelics for personal and communal use. This guide contains information on personal use, civil protections, and Colorado's regulated natural medicine access program. Natural psychedelics remain illegal under federal law. Please be conscientious and know the laws.
May 25, 2023
Sign up for Hemp and Cannabinoid Industry updates from Vicente LLP
By Joshua Kappel, Juliana Todeschi, George Winfrey
May 24, 2023
Another key step in bringing natural psychedelic medicine to Colorado was completed this week. Governor Polis signed SB23-290, the Natural Medicine Health Act’s implementation bill. This bill is the most comprehensive piece of legislation ever passed by a state government related to a state-authorized natural psychedelic medicine program. It builds upon the values of the NMHA with a renewed focus on indigenous voices, safety, and regulatory efficiency. The measure goes into effect on July 1, 2023. Read our full analysis of the bill.
By Michelle Bodian, Shawn Hauser, Shane Pennington
May 11, 2023
At a DEA supply chain conference last week, Terrance Boos, Section Chief, Drug and Chemical Evaluation Section, stated that the DEA will be releasing a rule to reschedule certain hemp-derived cannabinoids.
May 11, 2023
With ketamine being the only approved psychedelic drug for medical use, ketamine clinics offer a unique opportunity for investors and entrepreneurs looking to enter the expanding market of innovative mental health therapies. In this article, we will explore the reasons behind the growing demand for ketamine clinics and the unique regulatory considerations involved in transactions involving these businesses.
May 10, 2023
Vicente psychedelics and emerging therapies attorney Yolanda Clarke will share Oregon psilocybin licensing tips and insights at Psycon Oregon on May 19.
By Andrea Golan, Ashley Davies
May 4, 2023
Arkansas Act 629 prohibits the production and sale of intoxicating substances derived from hemp. The act also amends the definition of "industrial hemp" and includes a controversial "trigger provision." Learn more about it in this Insights article.
By Genevieve Meehan and Sara Simons
May 3, 2023
Since its introduction on April 18, SB23-290, the implementation bill for the Natural Medicine Health Act (NMHA), made its way through the Colorado Legislature and now awaits the governor's signature. Although the bill started off with a couple of policy positions that were antithetical to the voter-initiated act, after a series of amendments and a lot of work by Colorado activists and lawyers, it seems clear SB23-290 builds off the intent of the NMHA to create a natural psychedelic ecosystem in Colorado based in equity and safety. Read this Vicente Insights post for key aspects of the bill.
By Joshua Kappel
May 1, 2023
Since its introduction on April 18, SB23-290, the implementation bill for the Natural Medicine Health Act (NMHA), made its way through the Colorado House and has now passed with amendments that have generally brought this bill even closer to the original intent of Prop 122! Read this Vicente Insights post for the latest updates and next steps for the bill.
Apr 26, 2023
Join Shawn Hauser at the INCBA Hemp Symposium on April 28 to listen to her panel, “How the 2023 Farm Bill Can Reshape Hemp and Regulated Cannabinoid Policy.” Register now!
By Joshua Kappel, Juliana Todeschi
Apr 25, 2023
Since its introduction on April 18, SB23-290, the implementation bill for the Natural Medicine Health Act (NMHA), has gone through the Colorado Senate Finance and Appropriations Committees and several amendments have been made. The reengrossed version of the now 91-page bill heads to the state House with a new sponsor, Representative Judy Amabile. Read this Vicente Insights post for the latest updates and next steps for the bill.
By Joshua Kappel
Apr 21, 2023
SB23-290, the Natural Medicine Health Act (NMHA) implementation bill, had a hearing on April 20 in Colorado’s Senate Finance Committee. Amendments made during the hearing were a significant step in the right direction. Read this Vicente Insights post for our summary of the hearing and next steps for the bill.
By Joshua Kappel, Barine Majewska
Apr 19, 2023
SB23-290 was introduced in the Colorado Legislature to amend and implement Proposition 122, the Natural Medicine Health Act that was passed by Colorado voters in November. There will be a public hearing on this bill tomorrow, April 20. If passed, SB23-290 would completely replace the NMHA.
Apr 13, 2023
Making psychedelic-assisted therapy and training opportunities accessible to historically and systematically oppressed populations is essential to creating a more equitable healthcare model. But how can this be achieved? Watch this webinar for a discussion on equity and psychedelics with professionals from Alchemy Community Therapy Center.
Apr 4, 2023
Vicente attorneys Joshua Kappel and Jennifer Cabrera are participating in Trailblazers’ highly anticipated second annual event in New York City on April 24-25!
By Krissy Atterholt, Jason Tarasek
Mar 22, 2023
Microbreweries and cideries have become Minnesota THC beverage market leaders in the wake of 2022's hemp-derived THC product bill. The current cannabis legalization bill would have made things difficult for these producers, but it was recently amended so that lower-potency hemp edibles manufacturers could produce lower-potency hemp edibles at the same facility where food (such as beer or cider) is manufactured.
By Charles Alovisetti
Mar 22, 2023
A new industry is emerging in the United States, and entrepreneurs in the psychedelics space must make critical decisions at the onset of new ventures regarding how to set up and structure their new businesses. Luckily, we have access to another industry with a complex legal framework and a patchwork of different state laws: cannabis. And after forming hundreds of cannabis companies with clients over the past decade, Vicente LLP has lessons to be shared.
By Shane Pennington
Mar 1, 2023
How TGA's rescheduling of psilocybin and MDMA shines a bright light on DEA delinquency
Feb 23, 2023
Calling all cannabis and psychedelic industry professionals! RSVP to attend our private networking event and fundraiser during SXSW in Austin, co-hosted with Grasslands: A Journalism-Minded Agency.
By Krissy Atterholt
Feb 14, 2023
Michigan leads the Midwest in affording its communities local protection for psychedelic-based activities. This article gives a breakdown of notable moments in Michigan's psychedelic legislative history.
By Catie Wightman
Feb 13, 2023
In recent years, several CBD companies faced product liability lawsuits brought by consumers. Many of these cases were dismissed without prejudice or stayed until the FDA takes action to regulate CBD products. Now that the FDA said it will not take action to regulate CBD, could these cases be revived?
Feb 9, 2023
What is microdosing and what does the path to legalizing responsible psychedelic use look like? Get the low-down from the Third Wave Podcast featuring Josh Kappel, Alli Schaper and Marie Mbouni, M.D.
Feb 9, 2023
The FDA decided not to regulate CBD, denied three citizen petitions requesting CBD rulemaking or other FDA action, and announced it is now up to Congress to step in. Watch this webinar and learn what this means for your hemp-derived cannabinoids business.
By Catie Wightman
Feb 9, 2023
With recent announcements from the FDA pushing CBD and hemp-derived products further into a legal gray area, can veterinarians recommend or sell these products for pets?
By Yolanda Clarke and Jaime Greenwood
Feb 3, 2023
Colorado's Natural Medicine Health Act provides a path for responsible access to psychedelic natural medicines. If you're interested in the personal use of natural medicines in Colorado, read this article to find out what is and is not permitted.
By Sam Kovach-Orr
Jan 23, 2023
Vermont, Maryland, Virginia, Oregon, and Colorado recently issued reports containing policy recommendations relating to intoxicating hemp-derived products.
Jan 19, 2023
Join Shane Pennington on February 1 for a Cannabis Business Times webinar discussing the opportunities and challenges surrounding the federally legal cannabis seeds market.
By Catie Wightman
Jan 17, 2023
The SB 22-205 Intoxicating Hemp Task Force's final report makes legislative and rule recommendations concerning the regulation of intoxicating and synthetic hemp products in Colorado. We compiled 10 key takeaways for hemp industry stakeholders.
Jan 12, 2023
As states like Oregon and Colorado develop regulated pathways for people to get involved in the regulated psychedelics industry, possibilities—and questions—are increasing: What are the opportunities now, what’s next, and where? Get answers by watching this recorded session.
Jan 10, 2023
Certain psychedelics were decriminalized in Colorado, now what? Join Chacruna’s Community Forum on January 18 for an in-depth discussion about the Natural Medicine Health Act.
By Andrea Golan
Jan 6, 2023
Minnesota hemp companies are being sued by the Minnesota Board of Pharmacy for selling high-THC hemp-derived edibles that allegedly contained 100 milligrams of hemp-derived THC per gummy bear and were intentionally marketed in a manner that is appealing to children. What standards may lower consumer safety risks for these products?
Jan 6, 2023
"Can I start selling mushrooms in Colorado now?" Joshua Kappel answers your questions about Proposition 122 on the Psychedelics Passage podcast. Listen here!
By Catie Wightman
Jan 3, 2023
In this two-part VS Insights series, we discuss the potential legal implications for veterinarians to consider regarding cannabis and hemp products. This first article focuses on cannabis products, while part two focuses on hemp and hemp-derived products.
Dec 23, 2022
On January 7, 2023, the VS team will provide legal services at a drug conviction record sealing clinic in Denver, Colorado.
Dec 15, 2022
Watch as Vicente Sederberg LLP and EARTH Law LLC discuss the regulatory approaches for intoxicating hemp in Colorado, Oregon and California, and our projections for the future
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
By Yolanda Clarke, Jamie Greenwood
Nov 16, 2022
In another exciting step towards implementing psilocybin services, the Oregon Psilocybin Services Section issued updated proposed rules under the Oregon Psilocybin Services Act this month, making significant changes to the previous iteration. Make your voices heard! The public comment period is open through November 21, 2022.
Nov 4, 2022
Josh Kappel recently discussed everything related to Proposition 122: The Natural Medicine Health Act with Higher Practice Podcast. Listen now!
Nov 1, 2022
The November 2022 ballot has those interested in cannabis and psychedelic policy reform on their toes. From supporting adult-use cannabis initiatives in Arkansas, Missouri, North Dakota, South Dakota, and Maryland, to potential psychedelic reform in Colorado, there is plenty of excitement!
By Michelle Bodian, Catie Wightman
Nov 1, 2022
Planning to ship hemp or hemp-derived CBD products? Read this first.
By Andrea Golan
Oct 31, 2022
As Congress considers the next Farm Bill, hemp stakeholders and lawmakers are strongly advocating for reforms that will benefit the industry and consumers.
By Shawn Hauser, Ariane Beckman
Oct 19, 2022
Intoxicating hemp-derived edibles are permitted in Minnesota. Is this discriminatory against medical cannabis operators? One Minnesota medical cannabis operator filed a complaint against the MN Department of Health for that very reason.
By Joshua Kappel and Tucker Wentz
Oct 11, 2022
Vicente Sederberg LLP is proud to stand with Natural Medicine Colorado and support Proposition 122. This measure not only provides safe access to natural psychedelic medicines, but does so in a way that is grounded in equity and conscious capitalism while also protecting legacy communities and existing medicine keepers.
By Marc Ross
Oct 11, 2022
Colorado Prop 122, The Natural Medicine Health Act, requires that licensed entities participating in the Natural Medicine Regulated Access Program must meet specific ESG criteria.
By Colleen Mitchell, Yolanda Clarke
Oct 10, 2022
Prop 122 would create a regulated system for adults aged 21 and older to access natural psychedelic medicine, such as psilocybin, in a supervised setting to treat various mental health conditions. It would also allow for the cultivation, possession, personal use, and gifting of psychedelic medicine for adults aged 21 and older. Read this for an overview of the proposition’s key components.
Oct 5, 2022
Michelle Bodian will present on hemp compliance during AHPA’s Regulatory Congress virtual event on November 15.
By Shawn Hauser, Catie Wightman, Ariane Beckman
Sep 20, 2022
Like the US, regulators in the UK are struggling to find ways to best regulate CBD and other hemp-derived products—frustrating hemp businesses across the globe. Read this VS Insights article to learn how the UK is currently regulating CBD and key findings and recommendations from the ACMD's Consumer CBD Products Report.
By Sally Kent Peebles
Sep 9, 2022
Oregon Health Authority published the remaining draft rules to implement 'Measure 109' – the Oregon voter initiative passed in November 2020 which directed the OHA to license and regulate psilocybin products and the provision of psilocybin services. Read more about psilocybin licensing rules.
Sep 7, 2022
Don’t miss the Emergence Psychedelic Education Festival on October 1, 2022. The event will feature psychedelic practitioners and advocates, including VS’s Barine Majewska.
By Ariane Beckman, David Kramer
Aug 23, 2022
Health Canada recently released a report titled, “Review of cannabidiol: Report of the Science Advisory Committee on Health Products Containing Cannabis.” Learn about the findings in this VS Insights article.
By Andrea Golan
Aug 22, 2022
California OEHHA adopted new regulations which include new non-mandatory Proposition 65 warning language for products that can expose consumers to cannabis smoke or delta-9-THC.
By Catie Wightman, Ariane Beckman
Aug 11, 2022
The FDA is cracking down on companies making unlawful drug or disease claims about their products relating to CBD by recently issuing several warning letters to address these compliance violations.
Aug 10, 2022
Josh Kappel will be featured in a legalization and regulation panel at the Psychedelic Law Summit hosted by InsidePractice, "Legalization or Regulation: Pathways to Psychedelic Access"
Aug 8, 2022
VS founding partner Joshua Kappel was a featured guest on a panel hosted by Into The Multiverse Podcast to discuss the history and future of psychedelic microdosing.
Jul 28, 2022
VS partner Shawn Hauser is slated to participate in a hemp- and cannabis-focused session at the upcoming AICPA & CIMA Agriculture Industry Conference.
Jul 28, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
Jul 28, 2022
The All-Party Parliamentary Group (APPG) for CBD Products recently delivered "A Plan for a Legal and Regulated UK Hemp and Cannabis Sector" to the UK Government. Shawn Hauser and Andrew Livingston contributed to the business plan, which offers an industry analysis and series of recommendations to create a well-regulated, multi-faceted and competitive UK cannabis industry.
By Andrea Golan and Ariane Beckman
Jul 25, 2022
Continuing to keep a close eye on key states to watch in 2022, this article focuses on recent hemp- and cannabinoid-related legislation in Louisiana: Act No. 498. To create a thriving hemp market in Louisiana, we believe legislators should clarify the Act’s language before the deadline.
Jul 22, 2022
Joshua Kappel was interviewed by Psychedelica Lex to discuss his advocacy for the Colorado Natural Medicine Health Act, a measure on the Fall ballot.
Jul 22, 2022
It's official! Coloradans will have the chance to vote on a historic ballot initiative this year to legalize possession of certain psychedelics, establish a therapeutic model for supervised psilocybin treatment and provide a pathway for record sealing for prior convictions.
Jul 6, 2022
VS is excited to announce that the prestigious international legal directory Chambers & Partners awarded VS with the 'Cannabis Law Firm of the Year' award once again, extended VS a Band 1 ranking for the fourth straight year, and recognized five VS attorneys as top cannabis lawyers.
By Andrea Golan
Jul 6, 2022
CDPH published Industrial Hemp Enrollment and Oversight Authorization and registration for each hemp product type.
Jun 29, 2022
VS partner Shawn Hauser visited the Palace of Westminster in London on June 29th to speak with members of Parliament about the economic benefits and lessons learned from cannabis legalization in Colorado and other states.
By Catie Wightman, Shawn Hauser
Jun 16, 2022
We recently hosted a webinar exploring intoxicating hemp-derived products. Read this for key takeaways from the session.
By Jamie Greenwood
Jun 6, 2022
The State of Colorado is convening a task force to collaborate on a report concerning intoxicating hemp products. Participate in the process by joining the task force, attending meetings, and submitting public comments!
By Charlie Alovisetti, Genevieve Meehan, Josh Kappel
May 27, 2022
Do commercial opportunities for entrepreneurs exist in psychedelics? We explore the current limited legal pathways and potential opportunities via proposed legislation and ballot initiatives in this article.
May 23, 2022
International Cannabis Bar Association's annual conference will feature VS attorneys Shawn Hauser and Shane Pennington in sessions focused on emerging cannabinoids and the CLI's first-ever moot court (Sisley v. DEA), respectively.
May 17, 2022
Watch this VS live session for a timely discussion exploring intoxicating hemp-derived products.
May 11, 2022
On May 19, 2022, a live INCBA CLE webinar about cannabis licensing in New York will feature VS counsel Michelle Bodian.
By Andrea Golan
May 6, 2022
CDPH published proposed emergency regulations detailing the registration requirements and annual fees for manufacturers of hemp extract and hemp products. CDPH is accepting public comments through May 31, 2022.
By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
Apr 14, 2022
Update on the lawsuit HIA & RE Botanicals, Inc v. DEA and why this case is critical to the hemp industry's future.
Apr 4, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
Apr 1, 2022
Watch this session exploring trending topics in hemp. During the session, members of our hemp team dive into the legality, regulation, and lawsuits surrounding minor cannabinoids, current federal hemp legislation, and what we expect and hope to see in the 2023 Farm Bill.
By Michelle Bodian, Jace Pohlman
Mar 30, 2022
The FDA and FTC are working together to target fraudulent COVID-19 claims made by CBD companies. Seven CBD product companies received warning letters. Read this article for a look into what to do—or not do—to avoid a warning.
Mar 28, 2022
Watch this session to learn more about the New York adult-use cannabis conditional cultivator license and how you can prepare.
By Shane Pennington
Mar 25, 2022
Reps. Nancy Mace and Barbara Lee recently filed a resolution imploring President Biden to push the UN to remove cannabis from the list of controlled substances in the Single Convention on Narcotic Drugs of 1961. Taking this proposal seriously may prevent the DEA from placing hemp back on the federal CSA schedules.
Mar 7, 2022
We're thrilled to announce that VS partner Shawn Hauser earned a spot on the Denver Business Journal’s 26th annual “40 under 40” list!
Mar 4, 2022
We look forward to seeing our colleagues, clients, and friends in person this month at the New England Cannabis Convention (NECANN)! Michelle Bodian, Jeremy Shaw, and David Ullian are slated to present in hemp and cannabis sessions.
By Michelle Bodian, Jennifer Cabrera
Feb 16, 2022
The law is intended to accelerate the cultivation, processing, and distribution of cannabis in New York.
By David Kramer
Feb 7, 2022
California is hoping that this will be the year that its hemp industry emerges from the shadows and takes its place among the nation's hemp leaders. Read this article for an outline of what hemp operators should expect from the CDPH and California's hemp program in the coming months.
Jan 19, 2022
Watch this live session on Thursday, January 27 at 12 p.m. MT to explore the latest in local and national psychedelics policy, with a focus on initiatives in Colorado and Denver.
By Shawn Hauser
Jan 6, 2022
Since hemp was federally legalized, the industry has dealt with constantly changing rules, despite being in regulatory purgatory due to snail-paced progress from the FDA. Will circumstances change in 2022?
By Michelle Bodian, Catie Wightman
Dec 17, 2021
After several extensions, the 2014 Farm Bill is finally set to expire on Dec. 31. What's next for state hemp programs and what are the 2018 Farm Bill's notable requirements?
Dec 13, 2021
Update on psychedelics-related legislation and rulemaking, regulatory changes, and other noteworthy psychedelics news and events.
Dec 7, 2021
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Charles Alovisetti, Joshua Kappel, Andrea Golan
Dec 2, 2021
As we wait for federal legalization and/or state-regulated psilocybin markets to emerge, what can a motivated entrepreneur interested in mycelium pursue?
By Andrea Golan, Jace Pohlman
Nov 3, 2021
USPS Final Rule bans e-cigarettes and all vaping products, including those containing hemp-derived ingredients unless a business-to-business or regulatory exception is met.
Oct 20, 2021
VS attorneys Michelle and Brandon are slated to join the panel "Opportunities at the Intersection of Hemp and Marijuana" on Friday, November 5 at CWCB Expo in New York City.
Oct 19, 2021
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Shane Pennington
Oct 18, 2021
An introduction to the different registrations available for schedule I substances such as psilocybin and psilocin.
By James Nechleba
Oct 6, 2021
How can mental health practitioners map the new territory of psychedelics use in mental health therapy and stay within Colorado law?
By Andrea Golan, David Kramer
Oct 6, 2021
California AB-45 was signed into law by Governor Newsom, finally putting the California Department of Public Health’s infamous July 2018 FAQ in the rearview mirror—meaning foods, beverages, dietary supplements, pet products, and cosmetics containing CBD can be sold under California state law!
Sep 22, 2021
Barine Majewska presented an entheogen-focused CLE, The Red Flags and Grey Areas in Psychedelic Practice, which illuminates the top 10 issues that attorneys should consider when counseling clients in the psychedelic space.
Sep 14, 2021
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Shane Pennington
Sep 13, 2021
Texas has allowed hemp cultivation and state-based manufacturing, distribution, and retail sale of hemp and consumable hemp products since 2019—but only if the products weren’t intended for smoking. This prohibition on a product with such high value for hemp farmers—and soaring consumer demand—was sure to make waves.
Sep 2, 2021
Don't miss these ESG, hemp, and compliance-focused panels with the Vicente Sederberg team at NECANN Boston cannabis conference on September 10-11, 2021.
By Jonathan Cherkoss
Aug 30, 2021
Oregon voters passed two of the nation’s most sweeping drug policy reform measures in U.S. history in 2020, energizing grassroots organizers in Colorado and across the country. What's next for decriminalization and psychedelics reform in Colorado?
By Shawn Hauser
Aug 25, 2021
Recent NDIN notification objections from the FDA give us more insight into the agency's factors differentiating "full spectrum" hemp from CBD.
Aug 20, 2021
VS attorney Michelle Bodian discusses the hemp industry's environmental challenges and opportunities in this on-demand CLE from the INCBA
Aug 13, 2021
Vote for the VS-led panel "Psychedelics Ecosystem: Collaboration & Community" to be included in SXSW 2022!
Aug 11, 2021
With a new Administration and Congress, changes in personnel at FDA, and new safety data being published, is 2021 the year when CBD will come out from under the FDA shadows to be legally marketed in all 50 states?
By Barine Majewska
Aug 4, 2021
When we discuss inclusivity in the quickly emerging psychedelic industry, it is important to also acknowledge the inclusivity of different viewpoints about the administration of psychedelic medicine.
Aug 2, 2021
VS partner Shawn Hauser will discuss hemp and cannabinoids during a SupplySide Network 365 Education Series workshop with Natural Products Insider on August 19, 2021.
By Jace Pohlman, Law Clerk
Jul 30, 2021
As part of National Hemp Month, we're highlighting beneficial ways to use hemp and hemp products in our daily lives. This post will focus on using hemp in foods and beverages.
Jul 28, 2021
VS entheogens and emerging therapies attorney Barine Majewska, alongside other leaders in the psychedelic and drug policy space will explore political and policy avenues for ending the war on drugs in this upcoming forum.
By Shawn Hauser, Jace Pohlman
Jul 28, 2021
In this article, we lay out the CAOA’s key provisions governing hemp, related cannabis product regulation, and areas where legislators specifically seek industry feedback to inform the best policy approach.
By Jace Pohlman, Law Clerk
Jul 23, 2021
As part of National Hemp Month, we're highlighting beneficial ways to use hemp and hemp products in our daily lives. This post will focus on using hemp in paper and plastic materials.
By Shawn Hauser
Jul 22, 2021
In this article, we’ll look at the history of CBD regulation in the United States, the trends that are dominating CBD regulation in 2021, and some of the state-specific regulations in the largest states.
By Jace Pohlman, Law Clerk
Jul 14, 2021
As part of National Hemp Month, we're highlighting beneficial ways to use hemp and hemp products in our daily lives. This post will focus on using hemp in buildings and construction, opening the door to stronger structures, unique designs, and an overall positive impact on the environment.
By Catie Wightman, Jace Pohlman
Jul 13, 2021
Move over CBD; there are new cannabinoids in town. CBD has been the most sought-after and utilized hemp-derived cannabinoid in consumer products, but due in part to technological advances, various other hemp-derived cannabinoids, like CBG, CBN, and CBC, are now creating a well-deserved buzz.
By Caitlin Wightman, Michelle Bodian, Jace Pohlman
Jun 15, 2021
Over the first half of 2021, many states passed laws, implemented, or proposed new regulations regarding hemp cultivation, processing, and CBD products. These changes range from updates to testing, labeling, and packaging requirements, to adjustments in license requirements and limits on the types of hemp-derived products that can be sold.
Jun 10, 2021
Update on hemp legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
May 27, 2021
VS counsel Shane Pennington joined attorney Marc Hauser to discuss the legal and regulatory landscape surrounding Delta-8 in this recent podcast.
May 26, 2021
VS counsel Shane Pennington joined Rod Kight and Hemp Industries Association to discuss the lawsuit against DEA, challenging the DEA's interim final rule.
By Vicente Sederberg LLP
May 24, 2021
Read the memo VS delivered to the International Narcotics Control Board, which gives draft guidelines on control requirements for medical and scientific cannabis and discusses the implications and important issues for consideration.
By Michelle Bodian, David M. Ullian
May 24, 2021
If you’re a Massachusetts cannabis retailer who is interested in selling hemp products at your store, you're probably wondering how to comply with new guidance from the Cannabis Control Commission. This article should answer some of those burning questions.
May 13, 2021
Watch this recorded session to learn about the science, legality, and hemp market potential of minor cannabinoids.
May 7, 2021
Shawn will discuss the path forward for hemp-derived CBD at the Council for Responsible Nutrition's June 8-10 event.
May 4, 2021
Colorado Law Executive Education and CU Leeds School of Business are offering an online Cannabis Entrepreneurship Academy on Fridays during June 2021. The academy will tackle many cannabis business issues, including leadership, financing, regulations, markets, and more!
By Brian Vicente
Apr 19, 2021
The cannabis industry is complex. Prospective cannabis business owners and other service providers interested in working with cannabis businesses are wise to take a step back and assess what it really takes to not only enter the cannabis industry, but to succeed in it.
Mar 29, 2021
An updated overview and FAQ of the federal stimulus bills for coronavirus, with specific guidance for marijuana, hemp and ancillary businesses.
Mar 29, 2021
Vicente Sederberg is monitoring local, state, and federal responses to the coronavirus (COVID-19) and how they may impact cannabis businesses, service providers, and consumers.
Mar 24, 2021
Update on hemp legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Shawn Hauser
Mar 23, 2021
While we move closer to federal legalization, the great state of Texas remains an untapped major market—ripe for reform, but hard to move. Read this for opportunities to help bring about more responsible cannabis policies in the Lone Star State.
By Andrea Golan
Mar 17, 2021
On January 8, 2021, OEHHA proposed significant changes to its Prop 65 short form warning requirements. Public comments on the proposed changes can be submitted through March 29, 2021.
By Michelle Bodian
Feb 10, 2021
With state legislative sessions in full swing, plenty of hemp and CBD bills have been filed across the country.
By Michelle Bodian
Jan 19, 2021
VS's hemp team highlights a few notable provisions from the USDA final rule for hemp.
By Charles Alovisetti, Sally Kent Peebles
Jan 15, 2021
As more law firms are fielding client questions about cannabis industry transactions, it can be challenging for corporate counsel to identify when they need cannabis regulatory counsel.
By Caitlin Wightman, Michelle Bodian
Dec 23, 2020
On December 17, 2020, the Federal Trade Commission announced robust enforcement actions against companies making deceptive claims about CBD and CBG products.
By Vicente Sederberg LLP
Dec 18, 2020
Vicente Sederberg attorneys wrote the book on cannabis law — and now you can own it! This comprehensive primer on all things cannabis law is a must-have for anyone seeking to understand the major practical legal issues facing the marijuana and hemp industries.
By Shawn Hauser
Dec 1, 2020
This week marks a historic milestone in cannabis policy as both the United Nations and the U.S. House of Representatives consider modernizing prohibitionist cannabis laws.
By Vicente Sederberg LLP
Dec 1, 2020
For our 10th anniversary, we take a look back at VS's history of leadership in cannabis law, the marijuana and hemp industries, and drug policy reform.
By Vicente Sederberg LLP
Dec 1, 2020
Read the memo VS delivered to the International Narcotics Control Board, which contests current international controls of CBD preparations and discusses the potential impacts of reform.
Nov 25, 2020
Update on hemp legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Catie Wightman
Nov 16, 2020
If you are selling CBD products—even products sold exclusively online—you must follow retailer requirements in the states where you sell products (i.e., where your customers are located).
By Michelle Bodian
Oct 29, 2020
New York State Department of Health published draft regulations for the processing and retail sale of cannabinoid hemp.
Oct 22, 2020
Update on hemp legislation, regulatory changes, and other noteworthy hemp news and events.
By Elliot Y. Choi, Michelle Bodian
Oct 20, 2020
With the USDA interim final rule delayed, where does this leave states for the 2021 hemp growing season?
By Charles Alovisetti, Michelle Bodian, Elliot Choi
Oct 19, 2020
A brief history of cannabis regulation (including hemp) in the Commonwealth.
By Michelle Bodian
Sep 10, 2020
Two opportunities to submit public comments to protect the American hemp industry throughout all stages of the supply chain.
Sep 3, 2020
Andrea will present "What Attorneys Should Know About the Legal Status of Hemp and CBD Products in California and Beyond" on September 15, 2020.
Sep 2, 2020
Exotic Canopy Solutions LLC, represented by Vicente Sederberg LLP, filed a complaint against Eastern Colorado Hemp Operations, Inc. and Curnativ Farms LLC.
Aug 24, 2020
Update on hemp legislation, regulatory changes, and other noteworthy hemp news and events.
Aug 5, 2020
Learn about grant and loan opportunities for hemp farmers and hemp-related businesses in this session with VS's Michelle Bodian and Eric Steenstra of Vote Hemp.
Jul 21, 2020
Learn about efforts being made by Agricultural Hemp Solutions and Vote Hemp to align federal legislation and USDA rulemaking with the domestic hemp industry.
Jul 13, 2020
Update on hemp legislation, regulatory changes, and other noteworthy hemp news and events.
By Michelle Bodian, David Kramer
Jul 13, 2020
The past year has seen an uptick of hemp and CBD-related lawsuits across the country. This article explores the valuable lessons for hemp and CBD businesses to learn from a few of the cases.
By Courtney Barnes
Jul 6, 2020
House Bill 843, effective August 1, 2020, includes several notable amendments to Louisiana’s hemp production and CBD programs that will impact hemp-CBD businesses nationwide.
Jun 18, 2020
Don't miss Shawn's workshop focusing on managing legal risks for hemp-CBD in supplements on June 25.
By Michelle Bodian
Jun 10, 2020
As we reflect on hemp industry progress during Hemp Week, let's also take action to move this industry forward with the following vital initiatives...
Jun 4, 2020
Update on hemp legislation, regulatory changes, and other noteworthy hemp news and events.
By Corey Cox
May 28, 2020
The CBD-based medicine, Epidiolex, was descheduled by the DEA and is no longer a controlled substance. What are the implications of this change and what, if anything, does it mean for CBD products in general?
By Shawn Hauser
May 19, 2020
With its incredible farming communities, over 100 million acres of farmland, and large manufacturing and research infrastructure, Texas is poised to play a significant role in the U.S. hemp industry.
May 19, 2020
A coalition of U.S. hemp businesses and organizations announced the launch of Hemp for Our Future, a social responsibility campaign to support healthcare workers and community organizations on the frontline of the coronavirus crisis.
By Andrea A. Golan
May 7, 2020
The CARES Act provides many food- and agriculture-related benefits to the hemp industry to offset the immediate economic impacts of COVID-19.
By Shawn Hauser
May 6, 2020
Hemp for Our Future is a network of hemp businesses that support the production and donation of hemp-based materials, products, and foods to medical professionals and community organizations.
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian, Corey Cox
May 5, 2020
The continuing growth of the cannabis and hemp industries has given rise to the need for specifically tailored due diligence.
By Sally Kent Peebles, Caitlin Wightman
Apr 30, 2020
The hemp industry has arrived in Florida! After much anticipation, Florida farmers and hemp enthusiasts will finally be able to grow hemp right here in the Sunshine State.
By Shawn Hauser
Apr 28, 2020
Because hemp is federally legal, there is financial relief available to the industry, including loans, federal and state grants, and tax relief.
Apr 20, 2020
Shawn Hauser and Dwight Clark talked about SBA loans for cannabis businesses and political advocacy during Texas NORML's 420 Stream-A-Thon.
Apr 17, 2020
This virtual session, originally planned for SXSW 2020, features representatives from Vicente Sederberg, Canopy Growth Corporation, and Willie's Remedy discussing the future of the industry, its challenges, the environment, and more.
Apr 17, 2020
Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on hemp businesses, service providers, and consumers.
Apr 16, 2020
Update on hemp legislation, regulatory changes, and other noteworthy hemp news and events.
Apr 7, 2020
Attorneys from Vicente Sederberg and Kleinfeld Kaplan & Becker discuss the hemp and CBD industry, including important FDA updates in this webinar replay.
Apr 7, 2020
Watch the replay of this discussion on federal financial assistance and lending available for hemp and CBD businesses in light of the coronavirus pandemic.
Mar 24, 2020
A coalition of hemp industry stakeholders, including Vicente Sederberg LLP, released a second set of new policy recommendations for officials developing federally compliant state hemp programs.
By David Gately and David Kramer
Mar 23, 2020
A summary of recent hemp and CBD news and developments in light of coronavirus and federal updates from the FDA and USDA.
Mar 18, 2020
Vicente Sederberg LLP partner Shawn Hauser participated in Texas NORML's "State of Cannabis 2020." Watch it here!
Mar 12, 2020
Vicente Sederberg LLP has been working hard for many years to shape cannabis policy reform in Texas... and now we're pleased to announce that we've opened an office in Austin!
By Shawn Hauser, Partner
Mar 12, 2020
The FDA issued its first report to Congress, along with a public update regarding its progress in evaluating lawful pathways for the marketing of CBD products and considering a risk-based enforcement policy. Read the summary from VS Hemp Department leader, Shawn Hauser.
By Michelle Bodian
Mar 9, 2020
With any new consumer product craze, lawsuits will inevitably follow. The hemp-CBD industry is no exception. The current wave of CBD-related lawsuits has primarily been product liability claims.
Mar 2, 2020
Florida Department of Agriculture & Consumer Services are informing stakeholders on the intricacies of Florida hemp labeling requirements via webinars.
Mar 2, 2020
In this episode of the RiskWatch podcast, Shawn Hauser discusses how the legal cannabis landscape has changed over the years, how companies in the space can navigate regulatory compliance, and some core requirements for conducting due diligence.
By Shawn Hauser, Partner
Feb 27, 2020
The beginning of federally regulated hemp has been marred by industry-wide concerns about an overly restrictive federal program, and what may come from the USDA review of more than 4,600 comments to its interim final rule governing U.S. hemp production.
Feb 27, 2020
A coalition of hemp industry stakeholders, including Vicente Sederberg LLP, released new policy recommendations and an updated model plan for state hemp programs.
By Jennifer Cabrera, Counsel; Michelle Bodian, Senior Associate
Feb 6, 2020
A summary of New Jersey's USDA-approved hemp regulations and licensing program.
Feb 6, 2020
Update on hemp legislation, regulatory changes, and other noteworthy hemp news and events.
Jan 2, 2020
Update on hemp legislation, regulatory changes, and other noteworthy hemp news and events.
By Jennifer Cabrera, Counsel; David Kramer, Senior Associate; Michelle Bodian, Senior Associate
Dec 19, 2019
A summary of New York's newly signed hemp law, one of the most comprehensive state laws regulating the cultivation, manufacture, and sale of hemp and hemp extracts.
By Sahar Ayinehsazian, Associate Attorney
Dec 12, 2019
On December 3, 2019, a group of federal financial regulators took an important step to enable hemp operators to access banking services by publishing hemp banking guidance.
By Shawn Hauser, Partner; Corey Cox, Associate Attorney
Nov 27, 2019
The FDA issued an update on November 25, 2019, reiterating its position on CBD products in food and dietary supplements. What does this mean for your business?
By Elliot Choi, Counsel; Michelle Bodian, Senior Associate Attorney; Charles Alovisetti, Partner
Nov 15, 2019
Will USDA-issued hemp cultivation licenses be transferrable? Let's dive into the USDA interim final rule to find out.
Nov 14, 2019
VS Hemp & Cannabinoids attorney Shawn Hauser sat down with Kristen Nichols of Hemp Industry Daily to discuss the meaning and impact of the new hemp rules released by the USDA.
Nov 5, 2019
Watch VS's Hemp & Cannabinoids Practice Group attorneys and Eric Steenstra of Vote Hemp explain the interim final rule USDA Hemp Regulations and outline what you need to know for your business to remain compliant.
By Shawn Hauser, Partner; Michelle Bodian, Senior Associate Attorney; Corey Cox, Associate Attorney
Oct 30, 2019
Key takeaways from the USDA hemp cultivation regulations, including five expected provisions, five unexpected provisions, and five unanswered questions.
Oct 9, 2019
Hemp & Cannabinoids Practice Group attorney Corey Cox will speak about the legalities of CBD at the CBDExpo Mountain conference on October 12, 2019.
By Charles S. Alovisetti, Partner; Phil Silverman, Counsel; Jason Adelstone, Law Clerk
Sep 27, 2019
One of the many issues arising out of the tension between state and federal law in the cannabis industry is whether cannabis companies can access the protections of federal bankruptcy law.
By Charles S. Alovisetti, Partner
Sep 19, 2019
Despite news headlines saying that hemp is federally legal, many hemp-derived food products and supplements currently sold in the US are in violation of federal law. But some hemp food products can actually be sold in complete compliance with US Federal law. How so?
Aug 28, 2019
Attorney Courtney Barnes will speak at the annual Texas Marijuana Policy Conference on August 30, 2019 in Austin, Texas.
By Shawn Hauser, Partner; Michelle Bodian, Senior Associate Attorney; Caitlin Wightman, Law Clerk
Aug 23, 2019
Key takeaways from the U.S. Senate Agriculture Committee’s historic hearing on Thursday, July 25, 2019, where they discussed hemp production and related issues ahead of the release of federal rules.
Aug 8, 2019
The American Herbal Products Association (AHPA) will hold their first Hemp-CBD Supplement Congress on August 15-16, 2019 in Denver, Colorado. Several members of the Vicente Sederberg hemp team will be in attendance!
By Shawn Hauser, Partner; Courtney Barnes, Associate Attorney; Caitlin Wightman, Law Clerk
Jul 30, 2019
Here are five reasons why Texas is positioned to become one of the top hemp producers and researchers in the US, and potentially internationally.
Jul 17, 2019
Earlier this summer, Colorado Governor Jared Polis announced two major initiatives for Colorado’s marijuana and hemp industries: Colorado Hemp Advancement & Management Plan (CHAMP) and the Governor's Dashboard.
By Michelle Bodian, Senior Associate Attorney and Caitlin Wightman, Law Clerk
Jul 17, 2019
Since the passage of the 2018 Farm Bill on December 20, 2018, much has changed in the world of hemp. Here's a recap of major hemp-related developments.
By David Kramer, Associate Attorney
Jun 21, 2019
A number of hemp bills are passing through the California legislature. VS Attorney David Kramer dives deeper into AB-228 and SB-153.
Jun 19, 2019
Vicente Sederberg Attorneys Valerio Romano and Michelle Bodian will speak on cannabis and hemp at NECANN Springfield Cannabis Conference June 22-23, 2019.
Jun 17, 2019
VS Hemp Attorney David Kramer discusses CBD laws on a recent episode of Spectrum News 1 'Inside the Issues with Alex Cohen.'
Feb 28, 2019
Attorneys with Vicente Sederberg's Hemp and Cannabinoids Practice Group played a leading role in producing the American Hemp Campaign's model plan for state hemp programs, which will guide policymakers in the development of regulatory regimes governing hemp production across the U.S.